Aligos Therapeutics (ALGS) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)
Aligos Therapeutics' Gains (Losses) on Sale of Assets & Investments came in at -$1,000 for Q2 2026, compared with -$27,000 a year earlier.
Aligos Therapeutics (ALGS) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aligos Therapeutics reported Gains (Losses) on Sale of Assets & Investments of $22,000, down 24.1% year-over-year; for FY2025, it was $22,000, up 144.4% from FY2024.
- Gains (Losses) on Sale of Assets & Investments carries a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
- Going back by year, Gains (Losses) on Sale of Assets & Investments was $9,000 in FY2024 (-90.6%), $96,000 in FY2023 and -$57,000 in FY2022.
- The five-year range for quarterly Gains (Losses) on Sale of Assets & Investments is -$248,000 (Q1 2022) to $236,000 (Q4 2022).
- Business Quant data shows ALGS's Gains (Losses) on Sale of Assets & Investments at -$30,000 (Q1 2026), $18,000 (Q4 2025) and $35,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | -30,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | -69,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 98,000.00 |
| Dec 31, 2022 | 236,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | -154,000.00 |
| Mar 31, 2022 | -248,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -26,000.00 |
| Mar 31, 2021 | -41,000.00 |
| Dec 31, 2020 | -64,000.00 |
Aligos Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();